240 related articles for article (PubMed ID: 17003115)
1. Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation.
Iqbal J; Sun L; Kumar TR; Blair HC; Zaidi M
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14925-30. PubMed ID: 17003115
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro.
Balga R; Wetterwald A; Portenier J; Dolder S; Mueller C; Hofstetter W
Bone; 2006 Aug; 39(2):325-35. PubMed ID: 16580896
[TBL] [Abstract][Full Text] [Related]
3. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.
van't Hof RJ; Ralston SH
J Bone Miner Res; 1997 Nov; 12(11):1797-804. PubMed ID: 9383684
[TBL] [Abstract][Full Text] [Related]
4. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro.
Saleh H; Eeles D; Hodge JM; Nicholson GC; Gu R; Pompolo S; Gillespie MT; Quinn JM
Endocrinology; 2011 May; 152(5):1911-22. PubMed ID: 21363931
[TBL] [Abstract][Full Text] [Related]
6. TNFα inhibits the development of osteoclasts through osteoblast-derived GM-CSF.
Atanga E; Dolder S; Dauwalder T; Wetterwald A; Hofstetter W
Bone; 2011 Nov; 49(5):1090-100. PubMed ID: 21884837
[TBL] [Abstract][Full Text] [Related]
7. Chronic low dose tumor necrosis factor-α (TNF) suppresses early bone accrual in young mice by inhibiting osteoblasts without affecting osteoclasts.
Gilbert LC; Chen H; Lu X; Nanes MS
Bone; 2013 Sep; 56(1):174-83. PubMed ID: 23756233
[TBL] [Abstract][Full Text] [Related]
8. Immunization with FSHβ fusion protein antigen prevents bone loss in a rat ovariectomy-induced osteoporosis model.
Geng W; Yan X; Du H; Cui J; Li L; Chen F
Biochem Biophys Res Commun; 2013 May; 434(2):280-6. PubMed ID: 23537645
[TBL] [Abstract][Full Text] [Related]
9. Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis.
Redlich K; Görtz B; Hayer S; Zwerina J; Doerr N; Kostenuik P; Bergmeister H; Kollias G; Steiner G; Smolen JS; Schett G
Am J Pathol; 2004 Feb; 164(2):543-55. PubMed ID: 14742260
[TBL] [Abstract][Full Text] [Related]
10. Blocking antibody to the β-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesis.
Zhu LL; Blair H; Cao J; Yuen T; Latif R; Guo L; Tourkova IL; Li J; Davies TF; Sun L; Bian Z; Rosen C; Zallone A; New MI; Zaidi M
Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14574-9. PubMed ID: 22908268
[TBL] [Abstract][Full Text] [Related]
11. Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice.
Li P; Schwarz EM; O'Keefe RJ; Ma L; Looney RJ; Ritchlin CT; Boyce BF; Xing L
Arthritis Rheum; 2004 Jan; 50(1):265-76. PubMed ID: 14730625
[TBL] [Abstract][Full Text] [Related]
12. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
Hill PA; Reynolds JJ; Meikle MC
Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
[TBL] [Abstract][Full Text] [Related]
13. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
[TBL] [Abstract][Full Text] [Related]
14. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
[TBL] [Abstract][Full Text] [Related]
15. FSH directly regulates bone mass.
Sun L; Peng Y; Sharrow AC; Iqbal J; Zhang Z; Papachristou DJ; Zaidi S; Zhu LL; Yaroslavskiy BB; Zhou H; Zallone A; Sairam MR; Kumar TR; Bo W; Braun J; Cardoso-Landa L; Schaffler MB; Moonga BS; Blair HC; Zaidi M
Cell; 2006 Apr; 125(2):247-60. PubMed ID: 16630814
[TBL] [Abstract][Full Text] [Related]
16. The cellular actions of interleukin-11 on bone resorption in vitro.
Hill PA; Tumber A; Papaioannou S; Meikle MC
Endocrinology; 1998 Apr; 139(4):1564-72. PubMed ID: 9528935
[TBL] [Abstract][Full Text] [Related]
17. Follicle-stimulating hormone increases bone mass in female mice.
Allan CM; Kalak R; Dunstan CR; McTavish KJ; Zhou H; Handelsman DJ; Seibel MJ
Proc Natl Acad Sci U S A; 2010 Dec; 107(52):22629-34. PubMed ID: 21149714
[TBL] [Abstract][Full Text] [Related]
18. Osteoclast-derived complement component 3a stimulates osteoblast differentiation.
Matsuoka K; Park KA; Ito M; Ikeda K; Takeshita S
J Bone Miner Res; 2014 Jul; 29(7):1522-30. PubMed ID: 24470120
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase.
Kaji H; Sugimoto T; Kanatani M; Fukase M; Kumegawa M; Chihara K
J Bone Miner Res; 1996 Jan; 11(1):62-71. PubMed ID: 8770698
[TBL] [Abstract][Full Text] [Related]
20. Regucalcin stimulates osteoclast-like cell formation in mouse marrow cultures.
Yamaguchi M; Uchiyama S
J Cell Biochem; 2005 Mar; 94(4):794-803. PubMed ID: 15578574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]